Found: 155
Select item for more details and to access through your institution.
Skin health of community-living older people: a scoping review.
- Published in:
- Archives of Dermatological Research, 2024, v. 316, n. 6, p. 1, doi. 10.1007/s00403-024-03059-0
- By:
- Publication type:
- Article
Prevalence of anxiety and depression symptoms among patients with psoriasis in Kabul, Afghanistan.
- Published in:
- International Journal of Dermatology, 2024, v. 63, n. 8, p. e187, doi. 10.1111/ijd.17343
- By:
- Publication type:
- Article
Tree-Based Machine Learning to Identify Predictors of Psoriasis Incidence at the Neighborhood Level: A Populational Study from Quebec, Canada.
- Published in:
- American Journal of Clinical Dermatology, 2024, v. 25, n. 3, p. 497, doi. 10.1007/s40257-024-00854-3
- By:
- Publication type:
- Article
The association of age at psoriasis onset and HLA-C*06:02 with biologic survival in patients with moderate-to-severe psoriasis: a cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR).
- Published in:
- British Journal of Dermatology, 2024, v. 190, n. 5, p. 689, doi. 10.1093/bjd/ljad481
- By:
- Publication type:
- Article
Characteristics of 'super responders' and 'super nonresponders' to first biologic monotherapy for psoriasis: a nested case–control study.
- Published in:
- British Journal of Dermatology, 2024, v. 190, n. 3, p. 441, doi. 10.1093/bjd/ljad446
- By:
- Publication type:
- Article
Prevalence of multiple long-term conditions with psoriasis in England: A cohort study using the Clinical Practice Research Datalink.
- Published in:
- JEADV Clinical Practice, 2024, v. 3, n. 1, p. 117, doi. 10.1002/jvc2.285
- By:
- Publication type:
- Article
Implementing well‐being in the management of psoriasis: An expert recommendation.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2024, v. 38, n. 2, p. 302, doi. 10.1111/jdv.19567
- By:
- Publication type:
- Article
Risk of Paradoxical Eczema in Patients Receiving Biologics for Psoriasis.
- Published in:
- JAMA Dermatology, 2024, v. 160, n. 1, p. 71, doi. 10.1001/jamadermatol.2023.4846
- By:
- Publication type:
- Article
Risk of serious infection and infection mortality in patients with psoriasis: A nationwide cohort study using the Taiwan National Health Insurance claims database.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2024, v. 38, n. 1, p. 136, doi. 10.1111/jdv.19466
- By:
- Publication type:
- Article
Incidence and prevalence of generalized pustular psoriasis in multiethnic Johor Bahru, Malaysia: a population-based cohort study using routinely captured electronic health records in the Teleprimary Care (TPC<sup>®</sup>) clinical information system from 2010 to 2020
- Published in:
- British Journal of Dermatology, 2023, v. 189, n. 4, p. 410, doi. 10.1093/bjd/ljad158
- By:
- Publication type:
- Article
Effectiveness and survival of methotrexate versus adalimumab in patients with moderate-to-severe psoriasis: a cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR).
- Published in:
- British Journal of Dermatology, 2023, v. 189, n. 3, p. 271, doi. 10.1093/bjd/ljad179
- By:
- Publication type:
- Article
Prevalence of psoriasis and other autoimmune skin diseases in a recently contacted indigenous community in the Auaris region, Yanomami Indigenous Territory, Brazil.
- Published in:
- British Journal of Dermatology, 2023, v. 189, n. 3, p. 349, doi. 10.1093/bjd/ljad165
- By:
- Publication type:
- Article
Human Mast Cells Upregulate Cathepsin B, a Novel Marker of Itch in Psoriasis.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 17, p. 2177, doi. 10.3390/cells12172177
- By:
- Publication type:
- Article
Behaviour and sun exposure in holidaymakers alters skin microbiota composition and diversity.
- Published in:
- Frontiers in Aging, 2023, p. 1, doi. 10.3389/fragi.2023.1217635
- By:
- Publication type:
- Article
Imsidolimab, an anti-interleukin-36 receptor monoclonal antibody, for the treatment of generalized pustular psoriasis: results from the phase II GALLOP trial.
- Published in:
- British Journal of Dermatology, 2023, v. 189, n. 2, p. 161, doi. 10.1093/bjd/ljad083
- By:
- Publication type:
- Article
Acrodermatitis continua of Hallopeau and generalised pustular psoriasis: Should they be the same or different entities?
- Published in:
- Experimental Dermatology, 2023, v. 32, n. 8, p. 1235, doi. 10.1111/exd.14805
- By:
- Publication type:
- Article
Uptake of tumour necrosis factor-alpha inhibitor biosimilars for psoriasis: a drug utilization study from the British Association of Dermatologists Biologic and Immunomodulators Register (BADBIR).
- Published in:
- British Journal of Dermatology, 2023, v. 189, n. 1, p. 62, doi. 10.1093/bjd/ljad107
- By:
- Publication type:
- Article
O10 STAT3 activation in peripheral blood MAIT cells is a predictive biomarker of response to biologics targeting the IL-23/IL-17 axis.
- Published in:
- British Journal of Dermatology, 2023, v. 189, n. 1, p. e8, doi. 10.1093/bjd/ljad174.010
- By:
- Publication type:
- Article
Fertility Trends and Adverse Pregnancy Outcomes in Female Patients With Psoriasis in the UK.
- Published in:
- JAMA Dermatology, 2023, v. 159, n. 7, p. 736, doi. 10.1001/jamadermatol.2023.1400
- By:
- Publication type:
- Article
Effectiveness and persistence of acitretin, ciclosporin, fumaric acid esters and methotrexate for patients with moderate-to-severe psoriasis: a cohort study from BADBIR.
- Published in:
- British Journal of Dermatology, 2023, v. 188, n. 5, p. 618, doi. 10.1093/bjd/ljad004
- By:
- Publication type:
- Article
Access to psoriasis treatment in Brazil and Chile: A cross-sectional multicentre Global Healthcare Study on Psoriasis.
- Published in:
- British Journal of Dermatology, 2023, v. 188, n. 4, p. 533, doi. 10.1093/bjd/ljac128
- By:
- Publication type:
- Article
The effect of immunomodulators on seroconversion after BNT162b2 and AZD1222 vaccines in patients with immune-mediated inflammatory diseases: a prospective cohort study.
- Published in:
- British Journal of Dermatology, 2023, v. 188, n. 4, p. 542, doi. 10.1093/bjd/ljac109
- By:
- Publication type:
- Article
Migrant skin health: perspectives from the Migrant Health Summit, Malta, 2022.
- Published in:
- British Journal of Dermatology, 2023, v. 188, n. 4, p. 553, doi. 10.1093/bjd/ljad001
- By:
- Publication type:
- Article
Factors Predicting Quality of Life Impairment in Adult Patients with Atopic Dermatitis: Results from a Patient Survey and Machine Learning Analysis.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 4, p. 981, doi. 10.1007/s13555-023-00897-0
- By:
- Publication type:
- Article
A skin disease survey of the Maasai in North Eastern Tanzania.
- Published in:
- 2023
- By:
- Publication type:
- Letter
Prevalence, comorbidities and mortality of generalized pustular psoriasis: A literature review.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 2, p. 256, doi. 10.1111/jdv.18720
- By:
- Publication type:
- Article
Exploring Mast Cell–CD8 T Cell Interactions in Inflammatory Skin Diseases.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 2, p. 1564, doi. 10.3390/ijms24021564
- By:
- Publication type:
- Article
Comorbidities in Chilean patients with psoriasis: a Global Healthcare Study on Psoriasis.
- Published in:
- Clinical & Experimental Dermatology, 2022, v. 47, n. 12, p. 2234, doi. 10.1111/ced.15384
- By:
- Publication type:
- Article
Multifaceted amelioration of cutaneous photoageing by (0.3%) retinol.
- Published in:
- International Journal of Cosmetic Science, 2022, v. 44, n. 6, p. 625, doi. 10.1111/ics.12799
- By:
- Publication type:
- Article
Drug Survival Associated With Effectiveness and Safety of Treatment With Guselkumab, Ixekizumab, Secukinumab, Ustekinumab, and Adalimumab in Patients With Psoriasis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Reduced cutaneous CD200:CD200R1 signaling in psoriasis enhances neutrophil recruitment to skin.
- Published in:
- Immunity, Inflammation & Disease, 2022, v. 10, n. 7, p. 1, doi. 10.1002/iid3.648
- By:
- Publication type:
- Article
Safety of Ixekizumab in Adult Patients with Moderate-to-Severe Psoriasis: Data from 17 Clinical Trials with Over 18,000 Patient-Years of Exposure.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 6, p. 1431, doi. 10.1007/s13555-022-00743-9
- By:
- Publication type:
- Article
Cumulative Clinical Benefits of Biologics in the Treatment of Patients with Moderate-to-Severe Psoriasis over 1 Year: a Network Meta-Analysis.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 3, p. 727, doi. 10.1007/s13555-022-00690-5
- By:
- Publication type:
- Article
Incidence, Prevalence, and Mortality of People with Psoriasis and Psoriatic Arthritis in Taiwan: A Nationwide Cohort Study.
- Published in:
- Acta Dermato-Venereologica, 2022, v. 102, p. 1, doi. 10.2340/actadv.v102.1962
- By:
- Publication type:
- Article
Real-World Experience of Patient-Relevant Benefits and Treatment Satisfaction with Apremilast in Patients with Psoriasis: An Analysis of the APPRECIATE Study.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 1, p. 81, doi. 10.1007/s13555-021-00628-3
- By:
- Publication type:
- Article
Author Correction: Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Exploring the Quality of Communication Between Patients with Psoriatic Arthritis and Physicians: Results of a Global Online Survey.
- Published in:
- Rheumatology & Therapy, 2021, v. 8, n. 4, p. 1741, doi. 10.1007/s40744-021-00367-z
- By:
- Publication type:
- Article
Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-25066-9
- By:
- Publication type:
- Article
Psoriasis Prevalence in Adults in the United States.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Concordance and timing in recording cancer events in primary care, hospital and mortality records for patients with and without psoriasis: A population-based cohort study.
- Published in:
- PLoS ONE, 2021, v. 16, n. 7, p. 1, doi. 10.1371/journal.pone.0254661
- By:
- Publication type:
- Article
Peptide location fingerprinting reveals modification‐associated biomarker candidates of ageing in human tissue proteomes.
- Published in:
- Aging Cell, 2021, v. 20, n. 5, p. 1, doi. 10.1111/acel.13355
- By:
- Publication type:
- Article
Implementation of the PsoWell™ Model for the Management of People with Complex Psoriasis.
- Published in:
- Acta Dermato-Venereologica, 2021, v. 101, n. 4, p. 1, doi. 10.2340/00015555-3802
- By:
- Publication type:
- Article
Does the lifestyle of patients with psoriasis affect their illness?
- Published in:
- Advances in Hygiene & Experimental Medicine / Postepy Higieny i Medycyny Doswiadczalnej, 2021, v. 75, n. 1, p. 643, doi. 10.2478/ahem-2021-0033
- By:
- Publication type:
- Article
Randomized Trial Replication Using Observational Data for Comparative Effectiveness of Secukinumab and Ustekinumab in Psoriasis: A Study From the British Association of Dermatologists Biologics and Immunomodulators Register.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Prevalence of Atrophic and Hypertrophic Skin Ageing Phenotypes: A UK-based Observational Study.
- Published in:
- Acta Dermato-Venereologica, 2020, v. 100, n. 12, p. 1, doi. 10.2340/00015555-3708
- By:
- Publication type:
- Article
Association of Clinical and Demographic Factors With the Severity of Palmoplantar Pustulosis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Progress to Date in Advancing Stratified Medicine in Psoriasis.
- Published in:
- American Journal of Clinical Dermatology, 2020, v. 21, n. 5, p. 619, doi. 10.1007/s40257-020-00533-z
- By:
- Publication type:
- Article
Efficacy and Safety of Ixekizumab Through 5 Years in Moderate-to-Severe Psoriasis: Long-Term Results from the UNCOVER-1 and UNCOVER-2 Phase-3 Randomized Controlled Trials.
- Published in:
- Dermatology & Therapy, 2020, v. 10, n. 3, p. 431, doi. 10.1007/s13555-020-00367-x
- By:
- Publication type:
- Article
The relationship between PASI and DLQI with itch, stress, and depression: Do we need additional decision‐making tools in psoriasis?
- Published in:
- Dermatologic Therapy, 2020, v. 33, n. 3, p. 1, doi. 10.1111/dth.13276
- By:
- Publication type:
- Article
A randomised placebo controlled trial of anakinra for treating pustular psoriasis: statistical analysis plan for stage two of the APRICOT trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article